Northwest Biotherapeutics (NWBO) Announces DCVax-L + Keytruda Combo Phase in Colorectal Cancer
Go back to Northwest Biotherapeutics (NWBO) Announces DCVax-L + Keytruda Combo Phase in Colorectal CancerNORTHWEST BIO (AMEX: NWBO) | Delayed: 0.48 +0.02 (4.35%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.46 | 52 Week High | $5.19 | |||
Open | $0.47 | 52 Week Low | $0.32 | |||
Day High | $0.49 | P/E | N/A | |||
Day Low | $0.46 | EPS | $-3.72 | |||
Volume | 1,098,120 |